|
Technology
Pastel BioScience's main efforts are being
directed towards its development of the InVenio™
biomarker discovery & validation platform. To reach this end
goal
Pastel has had to develop and integrate individual technologies which
have significant applications in other fields.
Pastel will look
to realise value from these technologies through licensing and
collaborative research programmes. Some of the technologies that Pastel
is looking to partner are listed below.
- Novel
capture molecule technology :
Pastel has created a massive recombinant library
of capture molecules based on a totally novel human scaffold protein.
While Pastel is looking to apply these capture molecules to
its InVenio™
Technology there are potential applications as biological drug based
therapeutics analogous to the human antibody libraries that are
currently generating huge scientific, commercial and financial
investment interest .
- Ultra sensitive immunodiagnostic assay
: Pastel has identified and is currently in the process
of developing a method for obtaining ultra sensitive immunodiagnostic
assays that are likely to be orders of magnitude more sensitve and specific than
even the best current immunoassays. While the format will mean that
they will not be suitable for POC settings, they could have huge
potential in larger clinical laboratories and blood bank screening e.g.
p24 HIV testing.
If you are interested in any
of these technologies or the InVenio™
biomarker discovery & validation platform please contact us.
|
|